Scientists review the methodologies available for CD123 assessment and discuss the biological and clinical characteristics of patients for whom CD123-targeting therapies may have a clinical impact.
[Leukemia & Lymphoma]
6445212
88KLACQY
items
1
apa
0
default
asc
1
162387
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
